Source: Child's Nervous System. Unidades: FFCLRP, FMRP
Subjects: GLIOMA, QUIMIOTERAPIA ADJUVANTE, ASTROCITOMA, PEDIATRIA, EXPRESSÃO GÊNICA, SISTEMA NERVOSO CENTRAL
ABNT
CANDIDO, Marina Ferreira et al. NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature. Child's Nervous System, v. 36, n. 11, p. 2675-2684, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00381-020-04625-3. Acesso em: 18 out. 2024.APA
Candido, M. F., Baldissera, G. C., Medeiros, M., Umezawa, K., & Brassesco, M. S. (2020). NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature. Child's Nervous System, 36( 11), 2675-2684. doi:10.1007/s00381-020-04625-3NLM
Candido MF, Baldissera GC, Medeiros M, Umezawa K, Brassesco MS. NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature [Internet]. Child's Nervous System. 2020 ; 36( 11): 2675-2684.[citado 2024 out. 18 ] Available from: https://doi.org/10.1007/s00381-020-04625-3Vancouver
Candido MF, Baldissera GC, Medeiros M, Umezawa K, Brassesco MS. NF-кB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature [Internet]. Child's Nervous System. 2020 ; 36( 11): 2675-2684.[citado 2024 out. 18 ] Available from: https://doi.org/10.1007/s00381-020-04625-3